OUP Management as of March 31, 2023
Portfolio Holdings for OUP Management
OUP Management holds 14 positions in its portfolio as reported in the March 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Aerovate Therapeutics Common Stock (AVTE) | 24.3 | $12M | 604k | 20.17 | |
| Centessa Pharmaceuticals Sponsored ADS (CNTA) | 22.6 | $11M | 2.9M | 3.85 | |
| DICE Therapeutics Common Stock | 15.3 | $7.7M | 268k | 28.65 | |
| PMV Pharmaceuticals Common Stock (PMVP) | 9.4 | $4.7M | 989k | 4.77 | |
| Cyteir Therapeutics Common Stock | 8.9 | $4.5M | 2.5M | 1.82 | |
| ionQ Common Stock (IONQ) | 4.8 | $2.4M | 390k | 6.15 | |
| Vor Biopharma Common Stock (VOR) | 4.0 | $2.0M | 375k | 5.38 | |
| Prime Medicine Common Stock (PRME) | 3.0 | $1.5M | 121k | 12.30 | |
| Selecta Biosciences Common Stock (RNAC) | 2.4 | $1.2M | 863k | 1.39 | |
| Graphite Bio Common Stock | 2.0 | $996k | 406k | 2.45 | |
| Precision BioSciences Common Stock | 1.7 | $847k | 1.1M | 0.75 | |
| eFFECTOR Therapeutics Common Stock | 0.7 | $362k | 1.0M | 0.35 | |
| Spero Therapeutics Common Stock (SPRO) | 0.7 | $361k | 249k | 1.45 | |
| Homology Medicines Common Stock | 0.1 | $66k | 64k | 1.03 |
